These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23504536)

  • 1. Isoniazid could be used for antibiotic-loaded bone cement for musculoskeletal tuberculosis: an in vitro study.
    Han CD; Oh T; Cho SN; Yang JH; Park KK
    Clin Orthop Relat Res; 2013 Jul; 471(7):2400-6. PubMed ID: 23504536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Long Does Antimycobacterial Antibiotic-loaded Bone Cement Have In Vitro Activity for Musculoskeletal Tuberculosis?
    Lee JH; Han CD; Cho SN; Yang IH; Lee WS; Baek SH; Shin JW; Husein KEI; Park KK
    Clin Orthop Relat Res; 2017 Nov; 475(11):2795-2804. PubMed ID: 28795294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the Effectiveness and Mechanical Strength of Kanamycin-Loaded Bone Cement in Musculoskeletal Tuberculosis Compare to Vancomycin-Loaded Bone Cement.
    Lee JH; Shin SJ; Cho SN; Baek SH; Kim DH; Park KK
    J Arthroplasty; 2020 Mar; 35(3):864-869. PubMed ID: 31708292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid.
    Quenelle DC; Winchester GA; Staas JK; Barrow EL; Barrow WW
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1637-44. PubMed ID: 11353605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respirable rifampicin-based microspheres containing isoniazid for tuberculosis treatment.
    Cassano R; Trombino S; Ferrarelli T; Mauro MV; Giraldi C; Manconi M; Fadda AM; Picci N
    J Biomed Mater Res A; 2012 Feb; 100(2):536-42. PubMed ID: 22162280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Mycobacterium tuberculosis to a new macrolide antibiotic: RU-28965.
    Casal M; Gutierrez J; Gonzalez J; Ruiz P
    Tubercle; 1987 Jun; 68(2):141-3. PubMed ID: 3116734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY; Bilgin K; Uzun M; Durupinar B
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [First clinical isolate of Mycobacterium tuberculosis exhibiting resistance to rifampicin and sensibility to isoniazid in the Elche´s Health Department-General Hospital(1998-2015)].
    Ruiz-García MM; Grau Delgado J; Andrés Franch MI; Prats Sánchez I
    Rev Esp Quimioter; 2017 Feb; 30(1):55-56. PubMed ID: 27883163
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-Mycobacterium tuberculosis activity of naphthoimidazoles combined with isoniazid and rifampicin.
    Corrêa Barros LP; Del Rio KP; Carvalho TDSC; Pinto MDCFR; de Moura KCG; Halicki PCB; Ramos DF; da Silva PEA
    Tuberculosis (Edinb); 2018 Jul; 111():198-201. PubMed ID: 30029908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
    Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
    Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
    Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
    Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates.
    Ferraz-Carvalho RS; Pereira MA; Linhares LA; Lira-Nogueira MC; Cavalcanti IM; Santos-Magalhães NS; Montenegro LM
    Mem Inst Oswaldo Cruz; 2016 May; 111(5):330-4. PubMed ID: 27143488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of spinal tuberculosis in rabbits using bovine serum albumin nanoparticles loaded with isoniazid and rifampicin.
    Ma R; Zhang J; Chen Z; Ma H; Liu X; Liang S; Wu P; Ge Z
    Neurol Res; 2022 Mar; 44(3):268-274. PubMed ID: 34581255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biphasic nanohydroxyapatite/calcium sulphate carrier containing Rifampicin and Isoniazid for local delivery gives sustained and effective antibiotic release and prevents biofilm formation.
    Qayoom I; Verma R; Murugan PA; Raina DB; Teotia AK; Matheshwaran S; Nair NN; Tägil M; Lidgren L; Kumar A
    Sci Rep; 2020 Aug; 10(1):14128. PubMed ID: 32839480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).
    Drowart A; Cambiaso CL; Huygen K; Serruys E; Portaels F; Jann E; Van Vooren JP
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):284-8. PubMed ID: 9432378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous detection of Mycobacterium tuberculosis complex and resistance to Rifampicin and Isoniazid by MDR/MTB ELITe MGB® Kit for the diagnosis of tuberculosis.
    Bisognin F; Lombardi G; Finelli C; Re MC; Dal Monte P
    PLoS One; 2020; 15(5):e0232632. PubMed ID: 32365116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.